AIM: To compare the prevalence of antibiotic resistance found in nasopharyngeal Streptococcus pneumoniae between villages treated with topical tetracycline or systemic azithromycin as part of a trachoma control programme. METHODS: All children aged 1-10 years were offered either single dose oral azithromycin treatment (20 mg/kg) or a course of topical 1% tetracycline ointment, depending on the area. Treatment was given annually for 3 years. Six months after the third annual treatment in each village, children were surveyed for nasopharyngeal carriage of S pneumoniae and resistance was determined using broth dilution MIC technique. Children in two additional villages, which had not yet been treated, were also surveyed. RESULTS: Nasopharyngeal carriage of S pneumoniae was similar in the tetracycline treated, azithromycin treated, and untreated areas (p=0.57). However, resistance to tetracycline and azithromycin was distributed differently between the three areas (p=0.004). The village treated with topical tetracycline had a higher prevalence of tetracycline resistance than the other villages (p=0.010), while the oral azithromycin treated village had a higher prevalence of macrolide resistance than the other villages (p=0.014). CONCLUSIONS: Annual mass treatment with oral azithromycin may alter the prevalence of drug resistant S pneumoniae in a community. Surprisingly, topical tetracycline may also increase nasopharyngeal pneumococcal resistance. Topical antibiotics may have an effect on extraocular bacterial resistance.
AIM: To compare the prevalence of antibiotic resistance found in nasopharyngeal Streptococcus pneumoniae between villages treated with topical tetracycline or systemic azithromycin as part of a trachoma control programme. METHODS: All children aged 1-10 years were offered either single dose oral azithromycin treatment (20 mg/kg) or a course of topical 1% tetracycline ointment, depending on the area. Treatment was given annually for 3 years. Six months after the third annual treatment in each village, children were surveyed for nasopharyngeal carriage of S pneumoniae and resistance was determined using broth dilution MIC technique. Children in two additional villages, which had not yet been treated, were also surveyed. RESULTS: Nasopharyngeal carriage of S pneumoniae was similar in the tetracycline treated, azithromycin treated, and untreated areas (p=0.57). However, resistance to tetracycline and azithromycin was distributed differently between the three areas (p=0.004). The village treated with topical tetracycline had a higher prevalence of tetracycline resistance than the other villages (p=0.010), while the oral azithromycin treated village had a higher prevalence of macrolide resistance than the other villages (p=0.014). CONCLUSIONS: Annual mass treatment with oral azithromycin may alter the prevalence of drug resistant S pneumoniae in a community. Surprisingly, topical tetracycline may also increase nasopharyngeal pneumococcal resistance. Topical antibiotics may have an effect on extraocular bacterial resistance.
Authors: K C Chern; S K Shrestha; V Cevallos; H L Dhami; P Tiwari; L Chern; J P Whitcher; T M Lietman Journal: Br J Ophthalmol Date: 1999-12 Impact factor: 4.638
Authors: S O Holm; H C Jha; R C Bhatta; J S Chaudhary; B B Thapa; D Davis; R P Pokhrel; M Yinghui; M Zegans; J Schachter; K D Frick; L Tapert; T M Lietman Journal: Bull World Health Organ Date: 2003-07-07 Impact factor: 9.408
Authors: B D Gaynor; K A Holbrook; J P Whitcher; S O Holm; H C Jha; J S P Chaudhary; R C Bhatta; T Lietman Journal: Br J Ophthalmol Date: 2003-02 Impact factor: 4.638
Authors: A M Fry; H C Jha; T M Lietman; J S P Chaudhary; R C Bhatta; J Elliott; T Hyde; A Schuchat; B Gaynor; S F Dowell Journal: Clin Infect Dis Date: 2002-07-23 Impact factor: 9.079
Authors: K L O'Brien; M A Bronsdon; R Dagan; P Yagupsky; J Janco; J Elliott; C G Whitney; Y H Yang; L G Robinson; B Schwartz; G M Carlone Journal: J Clin Microbiol Date: 2001-03 Impact factor: 5.948
Authors: T B Hyde; K Gay; D S Stephens; D J Vugia; M Pass; S Johnson; N L Barrett; W Schaffner; P R Cieslak; P S Maupin; E R Zell; J H Jorgensen; R R Facklam; C G Whitney Journal: JAMA Date: 2001-10-17 Impact factor: 56.272
Authors: Vivian Schiedler; Ramesh C Bhatta; Yinghui Miao; Mariko Bird; Hem Jha; J S P Chaudary; Alicia M Fry; Thomas M Lietman Journal: Ophthalmic Epidemiol Date: 2003-02 Impact factor: 1.648
Authors: Jaya D Chidambaram; Mariko Bird; Vivian Schiedler; Alicia M Fry; Travis Porco; Ramesh C Bhatta; Hem Jha; J S P Chaudary; Bruce Gaynor; Elizabeth Yi; John P Whitcher; Susie Osaki-Holm; Thomas M Lietman Journal: Emerg Infect Dis Date: 2004-11 Impact factor: 6.883
Authors: Bruce D Gaynor; Yinghui Miao; Vicky Cevallos; Hem Jha; J S P Chaudary; Ramesh Bhatta; Susan Osaki-Holm; Elizabeth Yi; Julius Schachter; John P Whitcher; Thomas Lietman Journal: Emerg Infect Dis Date: 2003-05 Impact factor: 6.883
Authors: Robert E Fintelmann; Eliza N Hoskins; Thomas M Lietman; Jeremy D Keenan; Bruce D Gaynor; Vicky Cevallos; Nisha R Acharya Journal: Arch Ophthalmol Date: 2011-04
Authors: M Jayahar Bharathi; R Ramakrishnan; C Shivakumar; R Meenakshi; D Lionalraj Journal: Indian J Ophthalmol Date: 2010 Nov-Dec Impact factor: 1.848